A Report of a Symptomatic Progressive Myeloma during Pregnancy and Postpartum Period from Asymptomatic State

Author:

Elgabry Gehad1,Spencer Lydia1,Siddiqi Hisam1ORCID,Ojha Soumya2,Wandroo Farooq1ORCID

Affiliation:

1. Department of Haematology, Sandwell and West Birmingham Hospitals NHS Trust, West Bromwich B71 4HJ, UK

2. Department of Haematology, University Hospital Birmingham NHS Trust, Birmingham B15 2GW, UK

Abstract

 Multiple myeloma is a plasma cell malignancy that is most commonly observed in males in the sixth and seventh decade of life. The clinical scenario of multiple myeloma with concurrent pregnancy is considered to be very rare. We detail here the case of a young female with known IgG kappa multiple myeloma who was found to have a steady elevation of her IgG kappa paraprotein during pregnancy and symptomatic progression in the postpartum period. She delivered a healthy baby at 40 weeks gestation. We present a review of all reported cases of known multiple myeloma progressing during pregnancy and in the postpartum period, the treatments given, and their outcomes. The report also provides suggestions for diagnosis and management of myeloma during pregnancy in order to have an outcome of successful uncomplicated pregnancy with healthy offspring. 

Publisher

MDPI AG

Subject

Hematology

Reference29 articles.

1. (2022, November 01). Cancer Research UK. Available online: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/myeloma/incidence.

2. Multiple myeloma epidemiology and survival, a unique malignancy;Kazandjian;Semin. Oncol.,2016

3. (2022, November 01). Risks and Causes of Myeloma, Cancer Research UK Website. Available online: https://www.cancerresearchuk.org/about-cancer/myeloma/risks-causes.

4. Giordano (1965). Multiple myeloma and pregnancy. (1st case in the world literature). Matern. Infanc. Arq. Med. Sociais, 24, 158–184.

5. Diagnosis and management of multiple myeloma during pregnancy: A case report, review of the literature, and an update on current treatments;Magen;Ther. Adv. Hematol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3